News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,290 Results
Type
Article (87513)
Company Profile (807)
Press Release (773948)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233089)
Career Advice (4140)
Deals (39806)
Drug Delivery (139)
Drug Development (91275)
Employer Resources (203)
FDA (18293)
Job Trends (17406)
News (397469)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (128)
Alliances (56980)
ALS (147)
Alzheimer's disease (1689)
Antibody-drug conjugate (ADC) (262)
Approvals (18329)
Artificial intelligence (508)
Autoimmune disease (98)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (520)
Cancer (4113)
Cardiovascular disease (357)
Career advice (3562)
Career pathing (38)
CAR-T (252)
CDC (57)
Cell therapy (702)
Cervical cancer (33)
Clinical research (75735)
Collaboration (1436)
Company closure (4)
Compensation (949)
Complete response letters (62)
COVID-19 (2962)
CRISPR (84)
C-suite (613)
Cystic fibrosis (140)
Data (4792)
Decentralized trials (2)
Denatured (64)
Depression (113)
Diabetes (461)
Diagnostics (7102)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (242)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (99094)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133309)
Executive appointments (997)
FDA (20860)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1294)
Gene editing (177)
Generative AI (52)
Gene therapy (561)
GLP-1 (1033)
Government (5391)
Grass and pollen (8)
Guidances (372)
Healthcare (20938)
HIV (49)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (254)
Immuno-oncology (22)
Indications (58)
Infectious disease (3212)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (196)
Interviews (816)
IPO (17931)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (37)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (591)
Lymphoma (271)
Machine learning (32)
Management (66)
Manufacturing (665)
MASH (145)
Medical device (14903)
Medtech (14929)
Mergers & acquisitions (22775)
Metabolic disorders (1180)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (235)
Neuropsychiatric disorders (63)
Neuroscience (2752)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (60)
Obesity (569)
Opinion (315)
Ovarian cancer (140)
Pain (172)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (31)
Patents (427)
Patient recruitment (334)
Peanut (57)
People (66333)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23358)
Phase II (32859)
Phase III (24787)
Pipeline (2817)
Policy (300)
Postmarket research (3554)
Preclinical (10541)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (696)
Real estate (7422)
Recruiting (79)
Regulatory (28109)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (159)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (111)
Vaccines (1060)
Venture capital (67)
Weight loss (403)
Women's health (60)
Worklife (21)
Date
Today (30)
Last 7 days (776)
Last 30 days (2781)
Last 365 days (33401)
2025 (27826)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1282)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51057)
Australia (8976)
California (9750)
Canada (2918)
China (941)
Colorado (411)
Connecticut (432)
Delaware (279)
Europe (117308)
Florida (1437)
Georgia (322)
Hawaii (3)
Idaho (67)
Illinois (826)
India (55)
Indiana (481)
Iowa (20)
Japan (335)
Kansas (126)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1307)
Massachusetts (7294)
Michigan (318)
Minnesota (578)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2708)
New Mexico (32)
New York (2639)
North Carolina (1429)
North Dakota (10)
Northern California (4461)
Ohio (308)
Oklahoma (22)
Oregon (51)
Pennsylvania (2022)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (51)
South Dakota (1)
Southern California (3720)
Tennessee (152)
Texas (1534)
United States (35913)
Utah (294)
Virginia (253)
Washington D.C. (84)
Washington State (836)
West Virginia (4)
Wisconsin (100)
Wyoming (2)
There are 862,290 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GC Biopharma’s Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in ‘Vaccine’
November 3, 2025
·
4 min read
Sponsored
Viral Vector Manufacturing: Case Studies and Considerations from a CDMO Perspective
Optimization Through Culture, Quality Control and Regulatory Standards
November 3, 2025
·
14 min read
Press Releases
Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary
November 3, 2025
·
3 min read
Press Releases
Akeso’s Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer
November 3, 2025
·
7 min read
Press Releases
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
November 3, 2025
·
4 min read
Press Releases
New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner
November 3, 2025
·
4 min read
Press Releases
IntoCell and Xcellon Biologics Announce MOU to Expand Access to Next-Generation ADC Technologies
November 3, 2025
·
3 min read
Press Releases
AMGEN’S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
November 3, 2025
·
18 min read
Press Releases
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
November 3, 2025
·
1 min read
Press Releases
CS Interpharm and CS Diagnostics Pharma Complete Conversion of Preferred Shares to Common Stock, Strengthening CSDX’s Path to Consolidated Financial Reporting
November 2, 2025
·
5 min read
1 of 86,229
Next
